GlycoMark to Host Complimentary Educational Program for Healthcare Professionals in Support of National Diabetes Month
Posted on November 2, 2017 by glycowebadmin
New York, NY (November 2, 2017)—GlycoMark, Inc., the exclusive provider of the GlycoMark® Test, is sponsoring an educational webinar on hyperglycemia and the GlycoMark Test as part of Diabetes Awareness Month. The complimentary educational program is available to all healthcare professionals managing the more than 30 million Americans with diabetes. Sessions will be held November…
Read More
GlycoMark®, Inc. Partners with Sheil Medical Laboratory to Expand GlycoMark Test in the Northeast
Posted on April 11, 2017 by GlycoMark USA
Agreement Facilitates Greater Accessibility for Patients and Clinicians to Important Diabetes Test New York, NY (April 11, 2017) – GlycoMark, Inc. announced today a partnership with Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. GlycoMark is the only clinically available blood test that specifically indicates recent hyperglycemia in patients…
Read More
Using the HbA1c Test Wisely in Clinical Practice
Posted on October 23, 2015 by GlycoMark USA
Upcoming webinar by the American Association for Clinical Chemistry (AACC) warns of variants and adducts that may affect accuracy of A1c tests New York, NY (October 23, 2015) – An upcoming webinar hosted by the AACC will discuss potential pitfalls of the hemoglobin A1c test due to conditional interferences that can affect the accuracy…
Read More
New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions with Cardiovascular Outcomes and Mortality
Posted on October 23, 2015 by GlycoMark USA
NEW YORK, NY (October 23, 2015) – In a new study published by the medical journal Diabetes involving more than 11,000 subjects, the GlycoMark test was used to help define links between hyperglycemic excursions and increased incidence of cardiovascular disease and death1. The recently published study involved analysis from the Atherosclerosis Risk In Communities (ARIC)…
Read More
GlycoMark, Inc. Announces the GlycoMark® Test is Available Through a Nationwide Partnership with Bio Reference Laboratories
Posted on October 17, 2015 by GlycoMark USA
Agreement Facilitates Greater Accessibility For Patients and Clinicians of Important Diabetes Test New York, NY (October 17, 2015) – Glycomark, Inc., the United States commercialization channel for the Glycomark test, announced today that their assay for diabetes will be marketed nationwide through a partnership with BioReference Laboratories. The Glycomark® test is a clinically proven,…
Read More
